Global Migraine Treatment Market is Expected to Grow at CAGR of 12.4% in the Forecast Period of 2020 to 2027

Migraine Treatment Market is growing with factors such as increasing prevalence of migraine, along with the adverse effects of drugs which may obstruct the growth of the market in the given forecast period.  

Global Migraine Treatment Market Scenario                                            

According to Data Bridge Market Research, the market for migraine treatment in North America region has the highest market share in global migraine treatment market. Market leader is Amgen Inc. which accounts an estimated market share of approximately 23.44%. The company has gained outstanding sale through providing migraine treatment drugs.      

  • In May, Amgen Inc. received approval for Aimovig from FDA for migraine treatment in adults. Aimovig acts by blocking calcitonin gene- related peptide receptor (CGRP-R) which has played an important role in migraine. This new drug for migraine treatment proved to be an effective remedy for migraine patients all over the world.

Migraine Treatment Market Trends Impacting the Market

Now the question is which other regions Amgen Inc., Eli Lilly and Company and   GlaxoSmithKline plc are targeting? Data Bridge Market Research has estimated a large growth in North America migraine treatment market and the market leaders targeting the U.S., Canada to be their next revenue pockets for 2020.  

The migraine treatment market is becoming more competitive with companies such as Amgen Inc., Eli Lilly and Company and GlaxoSmithKline plc. as they are the top dominating companies in migraine treatment having maximum number of drugs. Data Bridge Market Research new reports highlight the major growth factors and opportunities in the global migraine treatment market.   

For more analysis on the global migraine treatment market request for a briefing with our analysts

Global Migraine Treatment Market Development

  • In January 2020, Eli Lilly and Company announced that REYVOW C-V, 50 mg and 100 mg tablets is now available as an oral medication for acute migraine treatment in adults. This step taken by company proven to improve life of patients suffering from migraine headaches.

Scope of the Global Migraine Treatment Market

Global migraine treatment market is segmented on the basis of countries into the U.S.,  Canada, Mexico, Germany, France, U.K., Italy, Spain,  Russia,  Turkey, Belgium, Netherlands, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Switzerland, Rest Of Europe, Japan, China, South Korea, Australia, India, Singapore, Thailand, Malaysia, Indonesia, Vietnam, Philippines And Rest Of Asia-Pacific, Brazil, Argentina, Peru, Rest Of South America, South Africa, Saudi Arabia, UAE, Egypt, Kuwait, Israel And Rest of Middle East and Africa.

  • All country based analysis of global migraine treatment market is further analyzed based on further segmentation. Global migraine treatment market on the basis of types of migraine, the market is segmented into episodic, migraine with aura, chronic and others. On the basis of treatment the market is segmented into acute/abortive treatment, preventive/prophylactic treatment, non-pharmacological therapies and devices. On the basis of route of administration the market segmentations are oral, injectable, nasal sprays and others. On the basis of product type segments of market are prescription and over the counter, type, branded and generic are the two market segments. On the basis of end user the market is segmented into hospitals, clinics, homecare, others. On the basis of distribution channel, hospital pharmacies, retail pharmacies, online pharmacies and others are the market segments.

To know more about the global migraine treatment monitoring market, kindly contact us at :

Key Pointers Covered in Global Migraine Treatment Market Industry Trends and Forecast to 2027

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Recent Market Value for Different Countries
  • Market value and over view of migraine treatment market
  • Company profiling of top eight players of migraine treatment market

Key Market Competitors Covered in the Report

  • Eli Lilly and Company
  •  AstraZeneca
  •  Amgen Inc
  •  Allergan
  •  Pfizer Inc
  •  GlaxoSmithKline plc
  •  Biohaven Pharmaceuticals
  •  Teva Pharmaceuticals USA, Inc (A Subsidiary of Teva Pharmaceutical Industries Ltd)
  •  Bausch Health Companies Inc
  •  Abbott
  •  Dr. Reddy’s Laboratories Ltd
  •  Lundbeck
  •  Merck Sharp & Dohme Corp (A Subsidiary of Merck& Co. Inc.)
  •  Novartis AG
  •  Otsuka Pharmaceutical Co., Ltd (A Subsidiary of Otsuka Holdings Co., Ltd.)
  •  Catalent, Inc
  •  Bayer AG
  •  Sun Pharmaceutical Industries Ltd
  •  Neurelis, Inc
  • Zosano Phamra Corporation
  • Impel NeuroPharma, Inc

Above are the key players covered in the report, to know about more and exhaustive list of migraine treatment companies’, contact us

Research Methodology: Global Migraine Treatment Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Neurologists, Doctors, Surgeons, Healthcare Professionals
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@